Midwall ejection fraction for assessing systolic performance of the hypertrophic left ventricle

[1] Schussheim AE(1997)Usefulness of subnormal midwall fractional shortening in predicting left ventricular exercise dysfunction in asymptomatic patients with systemic hypertension Am J Cardiol 79 1070-1074

[2] Devereux RB(2008)Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy Hypertension 52 279-286

[3] de Simone G(2001)Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint Am J Cardiol 87 54-60

[4] Borer JS(2006)Evaluation of midwall systolic function in left ventricular hypertrophy: a comparison of 3-dimensional versus 2-dimensional echocardiographic indices J Am Soc Echocardiogr 19 802-810

[5] Herrold EM(1998)Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function Hypertension 31 929-936

[6] Laragh JH(2008)Is echo-determined left ventricular geometry associated with ventricular filling and midwall shortening in hypertensive ventricular hypertrophy? Echocardiography 25 20-26

[7] Biederman RW(1991)Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy Circulation 83 1676-1684

[8] Doyle M(2000)Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy Hypertension 36 755-759

[9] Young AA(1994)Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension J Am Coll Cardiol 23 1444-1451

[10] Devereux RB(2009)Quantitative assessment of left ventricular volume and ejection fraction using two-dimensional speckle tracking echocardiography Eur J Echocardiogr 10 82-88

[1] Schussheim AE(1997)Usefulness of subnormal midwall fractional shortening in predicting left ventricular exercise dysfunction in asymptomatic patients with systemic hypertension Am J Cardiol 79 1070-1074

[2] Devereux RB(2008)Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy Hypertension 52 279-286

[3] de Simone G(2001)Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint Am J Cardiol 87 54-60

[4] Borer JS(2006)Evaluation of midwall systolic function in left ventricular hypertrophy: a comparison of 3-dimensional versus 2-dimensional echocardiographic indices J Am Soc Echocardiogr 19 802-810

[5] Herrold EM(1998)Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function Hypertension 31 929-936

[6] Laragh JH(2008)Is echo-determined left ventricular geometry associated with ventricular filling and midwall shortening in hypertensive ventricular hypertrophy? Echocardiography 25 20-26

[7] Biederman RW(1991)Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy Circulation 83 1676-1684

[8] Doyle M(2000)Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy Hypertension 36 755-759

[9] Young AA(1994)Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension J Am Coll Cardiol 23 1444-1451

[10] Devereux RB(2009)Quantitative assessment of left ventricular volume and ejection fraction using two-dimensional speckle tracking echocardiography Eur J Echocardiogr 10 82-88